| 1. |
He S, Xia C, Li H, et al. Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors. Sci China Life Sci, 2024, 67(1): 122-131.
|
| 2. |
Zhang W, Zhu M, Xiang Y, et al. Current and future perspectives in unresectable locally advanced esophageal squamous cell cancer. Oncol Rep, 2024, 51(5): 65.
|
| 3. |
Sun L, Zhang Z, Xu J, et al. Dietary fiber intake reduces risk for Barrett's esophagus and esophageal cancer. Crit Rev Food Sci Nutr, 2017, 57(13): 2749-2757.
|
| 4. |
Xu SJ, Wang PL, Chen C, et al. Inflammatory and nutritional status influences outcomes of minimally invasive esophagectomy. World J Surg, 2023, 47(4): 1003-1017.
|
| 5. |
Li H, Miao Y, Zhong L, et al. Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation. Front Immunol, 2023, 14: 1162032.
|
| 6. |
Liu CA, Liu T, Li HC, et al. Nutrition impact symptoms: noteworthy prognostic indicators for lung cancer. Clin Nutr, 2023, 42(4): 550-558.
|
| 7. |
Bossi P, Delrio P, Mascheroni A, et al. The spectrum of malnutrition/cachexia/sarcopenia in oncology according to different cancer types and settings: a narrative review. Nutrients, 2021, 13(6): 1980.
|
| 8. |
Salas S, Cottet V, Dossus L, et al. Nutritional factors during and after cancer: impacts on survival and quality of life. Nutrients, 2022, 14(14): 2958.
|
| 9. |
Morgan E, Soerjomataram I, Rumgay H, et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology, 2022, 163(3): 649-658. e2.
|
| 10. |
Tang L, Shivappa N, Hebert JR, et al. Dietary inflammatory index and risk of oesophageal cancer in Xinjiang Uyghur Autonomous Region, China. Br J Nutr, 2018, 119(9): 1068-1075.
|
| 11. |
Chen QJ, Ou L, Li K, et al. Meta-analysis of the relationship between Dietary Inflammatory Index and esophageal cancer risk. Medicine (Baltimore), 2020, 99(49): e23539.
|
| 12. |
Jiang Y, Xu D, Song H, et al. Inflammation and nutrition-based biomarkers in the prognosis of oesophageal cancer: a systematic review and meta-analysis. BMJ Open, 2021, 11(9): e048324.
|
| 13. |
Han F, Liu Y, Cheng S, et al. Diagnosis and survival values of neutrophil-lymphocyte ratio (NLR) and red blood cell distribution width (RDW) in esophageal cancer. Clin Chim Acta, 2019, 488: 150-158.
|
| 14. |
Yang Q, Shen A, Chen X, et al. Clinical significance of nutrition and inflammation in esophageal cancer patients with surgery: a meta-analysis. Nutr Cancer, 2022, 74(9): 3128-3139.
|
| 15. |
Baba Y, Nomoto D, Okadome K, et al. Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma. Cancer Sci, 2020, 111(9): 3132-3141.
|
| 16. |
He YF, Luo HQ, Wang W, et al. Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation. Eur J Cancer Care (Engl), 2017, 26(2).
|
| 17. |
Wang C, Tong J, Tang M, et al. Pretreatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic factors and reference markers of treatment options for locally advanced squamous cell carcinoma located in the middle and upper esophagus. Cancer Manag Res, 2021, 13: 1075-1085.
|
| 18. |
Booka E, Kikuchi H, Haneda R, et al. Neutrophil-to-lymphocyte ratio to predict the efficacy of immune checkpoint inhibitor in upper gastrointestinal cancer. Anticancer Res, 2022, 42(6): 2977-2987.
|
| 19. |
Sakai M, Sohda M, Saito H, et al. Comparative analysis of immunoinflammatory and nutritional measures in surgically resected esophageal cancer: a single-center retrospective study. In Vivo, 2020, 34(2): 881-887.
|
| 20. |
Yang J, Zheng J, Qiu J, et al. Systemic immune-inflammatory index, tumor-infiltrating lymphocytes, and clinical outcomes in esophageal squamous cell carcinoma receiving concurrent chemoradiotherapy. J Immunol Res, 2023: 4275998.
|
| 21. |
Zeng X, Ye L, Luo M, et al. Prognostic value of pretreatment systemic immune-inflammation index in Chinese esophageal squamous cell carcinoma patients receiving radical radiotherapy: a meta-analysis. Medicine (Baltimore), 2023, 102(25): e34117.
|
| 22. |
Jhunjhunwala S, Hammer C, Delamarre L, et al. Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat Rev Cancer, 2021, 21(5): 298-312.
|
| 23. |
Suzuki T, Shimada H, Nanami T, et al. Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer. Surg Today, 2016, 46(12): 1394-1401.
|
| 24. |
Feng JF, Wang L, Jiang YH, et al. A novel prognostic index in patients with resectable esophageal squamous cell carcinoma: fibrinogen/prealbumin ratio. Rev Invest Clin, 2020, 72(1): 46-54.
|